pentazirinocyclodiphosphathiazene has been researched along with Adenocarcinoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cattan, A; Coninx, P; Deltour, G; Enger, A; Fournaise, R; Jezekova, D | 1 |
1 other study(ies) available for pentazirinocyclodiphosphathiazene and Adenocarcinoma
| Article | Year |
|---|---|
[Gas-liquid chromatographic assay of a new antineoplastic agent, 1,3,3,5,5-pentakis-(azaridino)lambda 6-2,4,6,3 lambda 5, 5 lambda 5-thiatriazadiphosphorine-1-oxide. Application to pharmacokinetic studies].
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Azirines; Chromatography, Gas; Female; Humans; Kinetics; Mice | 1984 |